Serveur d'exploration Chloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « oral »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
optogeneics < oral < oralis  Facettes :

List of bibliographic references indexed by oral

Number of relevant bibliographic references: 178.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000034 (2020) Vito Crincoli [Italie] ; Maria Grazia Piancino [Italie] ; Florenzo Iannone [Italie] ; Mariella Errede [Italie] ; Mariasevera Di Comite [Italie]Temporomandibular Disorders and Oral Features in Systemic Lupus Erythematosus Patients: An Observational Study of Symptoms and Signs
000041 (2020) Daiwei Wang [République populaire de Chine] ; Hong Qi [République populaire de Chine] ; Haoxing Zhang [République populaire de Chine] ; Wei Zhou [République populaire de Chine] ; Yanpeng Li [République populaire de Chine] ; Ang Li [République populaire de Chine] ; Qiong Liu [République populaire de Chine] ; Yun Wang [République populaire de Chine]TAF1L promotes development of oral squamous cell carcinoma via decreasing autophagy-dependent apoptosis
000080 (2020) Aimee Coscarart [États-Unis] ; Julianna Martel [États-Unis] ; Michael P. Lee [États-Unis] ; Alun R. Wang [États-Unis]Pembrolizumab-induced pseudoepitheliomatous eruption consistent with hypertrophic lichen planus.
000090 (2020) Yanli Tong [République populaire de Chine] ; Linlin Zheng [République populaire de Chine] ; Pingying Qing [République populaire de Chine] ; Hua Zhao [République populaire de Chine] ; Yanhong Li [République populaire de Chine] ; Linchong Su [République populaire de Chine] ; Qiuping Zhang [République populaire de Chine] ; Yi Zhao [République populaire de Chine] ; Yubin Luo [République populaire de Chine] ; Yi Liu [République populaire de Chine]Oral Microbiota Perturbations Are Linked to High Risk for Rheumatoid Arthritis
000104 (2020) Qiang Li [République populaire de Chine] ; Heng Dong [République populaire de Chine] ; Guangwen Yang [République populaire de Chine] ; Yuxian Song [République populaire de Chine] ; Yongbin Mou [République populaire de Chine] ; Yanhong Ni [République populaire de Chine]Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma
000106 (2020) Dargham B. M. Hammad [Royaume-Uni] ; S. L. Hider [Royaume-Uni] ; Veranja C. Liyanapathirana [Sri Lanka] ; Daniel P. Tonge [Royaume-Uni]Molecular Characterization of Circulating Microbiome Signatures in Rheumatoid Arthritis
000111 (2020) Kailin Chen [République populaire de Chine] ; Yajun Li [République populaire de Chine] ; Zhen Guo [République populaire de Chine] ; Yong Zeng [République populaire de Chine] ; Wei Zhang [République populaire de Chine] ; Hui Wang [République populaire de Chine]Metformin: current clinical applications in nondiabetic patients with cancer
000120 (2020) Célia Faustino ; Lídia PinheiroLipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
000182 (2020) Yoon Young Go [Corée du Sud] ; Ji Yoen Mun [Corée du Sud] ; Sung-Won Chae [Corée du Sud] ; Jiwon Chang [Corée du Sud] ; Jae-Jun Song [Corée du Sud]Comparison between in vitro toxicities of tobacco- and menthol-flavored electronic cigarette liquids on human middle ear epithelial cells
000227 (2020) Christopher Kwan [Australie] ; Suzana Milosevic [Australie] ; Helen Benham [Australie] ; Ian A. Scott [Australie]A rare form of dermatomyositis associated with muscle weakness and normal creatine kinase level
000254 (2019) Philippa M. Wells [Royaume-Uni] ; Frances M. K. Williams [Royaume-Uni] ; M. L. Matey-Hernandez [Royaume-Uni] ; Cristina Menni [Royaume-Uni] ; Claire J. Steves [Royaume-Uni]‘RA and the microbiome: do host genetic factors provide the link?
000264 (2019) Y H Wang [République populaire de Chine] ; G H Zhang [République populaire de Chine] ; L L Zhang [République populaire de Chine] ; J L Luo [République populaire de Chine] ; L. Gao [République populaire de Chine][Adrenal hemorrhage in a patient with systemic lupus erythematosus].
000316 (2019) Mingzhi Luo [République populaire de Chine] ; Kai Ni [République populaire de Chine] ; Yang Jin [République populaire de Chine] ; Zifan Yu [République populaire de Chine] ; Linhong Deng [République populaire de Chine]Toward the Identification of Extra-Oral TAS2R Agonists as Drug Agents for Muscle Relaxation Therapies via Bioinformatics-Aided Screening of Bitter Compounds in Traditional Chinese Medicine
000377 (2019) Shoko Murakami [Japon] ; Tatsuya Nagano [Japon] ; Kyosuke Nakata [Japon] ; Akira Onishi [Japon] ; Kanoko Umezawa [Japon] ; Naoko Katsurada [Japon] ; Masatsugu Yamamoto [Japon] ; Motoko Tachihara [Japon] ; Kazuyuki Kobayashi [Japon] ; Yoshihiro Nishimura [Japon]Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review
000413 (2019) Hongling Zhu [République populaire de Chine] ; Lianyong Liu [République populaire de Chine] ; Li Ren [République populaire de Chine] ; Junhua Ma [République populaire de Chine] ; Shuanggang Hu [République populaire de Chine] ; Zhaohui Zhu [République populaire de Chine] ; Xuemei Zhao [République populaire de Chine] ; Chao Shi [République populaire de Chine] ; Xing Wang [République populaire de Chine] ; Chaobao Zhang [République populaire de Chine] ; Mingjun Gu [République populaire de Chine] ; Xiangqi Li [République populaire de Chine]Systematic prediction of the biological functions of TAS2R10 using positive co-expression analysis
000420 (2019) Nesrine B. Zitouni ; Jean-Philippe Arnault ; Ali Dadban ; Christophe Attencourt [France] ; Catherine C. Lok ; Guillaume ChabySubacute cutaneous lupus erythematosus induced by nivolumab: two case reports and a literature review.
000498 (2019) Solomon Opoku [Ghana] ; Isaac Nyanor [Ghana]Qualitative and Quantitative Microbiological Studies of Paediatric Artemether-Lumefantrine Dry Powders and Paracetamol Syrups Obtained from Selected Drug Stores in Accra, Ghana
000547 (2019) Beni Lestari [Japon] ; Ikuko Nakamae [Japon] ; Noriko Yoneda-Kato [Japon] ; Tsumoru Morimoto [Japon] ; Shigehiko Kanaya [Japon] ; Takashi Yokoyama [Japon] ; Masafumi Shionyu [Japon] ; Tsuyoshi Shirai [Japon] ; Edy Meiyanto [Indonésie] ; Jun-Ya Kato [Japon]Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence
000549 (2019) Nguyen Minh Tuan ; Chang Hoon LeePenfluridol as a Candidate of Drug Repurposing for Anticancer Agent
000569 (2019) Sidharth Sonthalia ; Parul AggarwalOral Tofacitinib: Contemporary Appraisal of Its Role in Dermatology
000628 (2019) Amanda J. Iacano [États-Unis] ; Harvey Lewis [États-Unis] ; Jennie E. Hazen [États-Unis] ; Heather Andro [États-Unis] ; Jonathan D. Smith [États-Unis] ; Kailash Gulshan [États-Unis]Miltefosine increases macrophage cholesterol release and inhibits NLRP3-inflammasome assembly and IL-1β release

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "oral" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "oral" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    oral
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021